Hu Liu

Title: Hu Liu: Innovator in Antibody Therapeutics

Introduction

Hu Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of antibody therapeutics, particularly in the development of anti-PD-1 and anti-PD-L1 antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases, including cancers and autoimmune disorders.

Latest Patents

Hu Liu's latest patents include groundbreaking work on anti-PD-1 antibodies and their uses. These patents describe not only the antibodies themselves but also the nucleic acids encoding them, compositions that include these antibodies, and methods for their production. The applications of these antibodies are aimed at treating or preventing diseases such as cancers and autoimmune diseases. Additionally, he has developed anti-PD-L1 antibodies, which also encompass antigen-binding fragments, nucleic acids, and methods for their production and use in combating cancer, infectious diseases, and autoimmune conditions.

Career Highlights

Throughout his career, Hu Liu has worked with notable companies such as Shanghai Yunyi Healthcare and Technology Co., Ltd. and Jiangsu Hyamab Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Hu Liu has collaborated with several professionals in his field, including Lile Liu and Xinxiu Yang. These collaborations have further enriched his research and development efforts in antibody therapeutics.

Conclusion

Hu Liu stands out as an influential inventor in the realm of antibody therapeutics, with a focus on innovative treatments for serious diseases. His contributions through his patents and collaborations continue to impact the medical field positively.